carinoid cancer – Patient Worthy

Source: Pixabay

Midatech Pharma Gets Verbal Approval For MTD201 Continued Development

Post author:Meagan Fulps
Post published:January 16, 2018
Post category:Acromegaly Carcinoid Syndrome Rare Disease

Midatech Pharma just received verbal confirmation from Polish regulators to conduct the first European in-human study for a treatment that could potential aid those with carcinoid cancer and acromegaly, reported…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More